• Clinical Evidence

Goal Range Effect on Hypoglycemia Incidence for Intravenous Insulin Dosing

Setting: Cohort of five unaffiliated acute care hospitals.

Objective

This retrospective study examines the effect of goal range on incidence of hypoglycemia in patients receiving intravenous insulin therapy (managed with EndoTool).

Setting

Cohort of five unaffiliated acute care hospitals.

Results

  • Incidence of hypoglycemia <70 mg/dL was 35.5% lower with a goal range of 160-200 mg/dL goal range than a goal range of 100-140 mg/dL (0.22% vs 0.34% of blood glucose readings).
  • Whereas 73% of hypoglycemia events occurred following a blood glucose <120 mg/dL, 27% occurred following a blood glucose >120 mg/dL.

Conclusions

With use of EndoTool to manage intravenous insulin therapy, incidence of hypoglycemia may likely decrease by reducing the overall goal range spread concurrent to reducing the upper limit.

Objective

This retrospective study examines the effect of goal range on incidence of hypoglycemia in patients receiving intravenous insulin therapy (managed with EndoTool).

Setting

Cohort of five unaffiliated acute care hospitals.

Results
  • Incidence of hypoglycemia <70 mg/dL was 35.5% lower with a goal range of 160-200 mg/dL goal range than a goal range of 100-140 mg/dL (0.22% vs 0.34% of blood glucose readings).
  • Whereas 73% of hypoglycemia events occurred following a blood glucose <120 mg/dL, 27% occurred following a blood glucose >120 mg/dL.
Conclusions

With use of EndoTool to manage intravenous insulin therapy, incidence of hypoglycemia may likely decrease by reducing the overall goal range spread concurrent to reducing the upper limit.

References

Authors

Anderson Schrader; W. Patrick Burgess; Laurel Fuqua.

Source

Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.

Year

2019

Quick navigation
Objective
Setting
Results
Conclusions
References
Objective

This retrospective study examines the effect of goal range on incidence of hypoglycemia in patients receiving intravenous insulin therapy (managed with EndoTool).

Setting

Cohort of five unaffiliated acute care hospitals.

Results
  • Incidence of hypoglycemia <70 mg/dL was 35.5% lower with a goal range of 160-200 mg/dL goal range than a goal range of 100-140 mg/dL (0.22% vs 0.34% of blood glucose readings).
  • Whereas 73% of hypoglycemia events occurred following a blood glucose <120 mg/dL, 27% occurred following a blood glucose >120 mg/dL.
Conclusions

With use of EndoTool to manage intravenous insulin therapy, incidence of hypoglycemia may likely decrease by reducing the overall goal range spread concurrent to reducing the upper limit.

References

Authors

Anderson Schrader; W. Patrick Burgess; Laurel Fuqua.

Source

Presented at American Association of Clinical Endocrinologists Scientific & Clinical Congress.

Year

2019

Short and Sweet Headlines are Best!

Related posts

Image
  • Clinical Evidence

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

Using EndoTool to Optimize Insulin Management in DKA Patients with Renal Impairment

The objective of this study was to evaluate the impact of renal insufficiency on hypoglycemia rates in patients treated for Diabetic Ketoacidosis (DKA) utilizing a computerized insulin dosing algorithm.
Image
  • Clinical Evidence

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

20 minute read

Achieving Optimal Glucose Control in Critical Care Units at Atrium Health

The objective of this study was to evaluate the impact of different blood glucose (BG) target ranges for IV insulin infusions on inpatient glucose metrics, specifically focusing on hypo and hyperglycemic events, duration of IV insulin therapy, and length of stay (LOS) in the hospital.
Image
  • Clinical Evidence

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

Atrium Health Lowers Hospital Stay for DKA Patients, Yielding $12 Million in Savings

To compare the effectiveness of EndoTool IV in reducing hospital LOS and hypoglycemia rates compared to standard insulin infusion protocols.
Get in Touch

Ready to get started?

Fill in your details and one of our friendly team members will be in touch to show you how easily EndoTool can support your hospital.

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.